ResearcherHarvard UniversityActive in the last 2 years
Mark S. Duxbury
Matched on OpenAlex author ID A5109084855. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2023: 7 papers · 2024: none · 2025: 3 papers
Papers 10
- Editor's Note: A Novel Role for Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 as a Determinant of Gemcitabine Chemoresistance in Pancreatic Adenoca… Co-author DOI 10.1158/0008-5472.can-25-0886↗
- Retraction: Prostaglandin E2 Enhances Pancreatic Cancer Invasiveness through an Ets-1-Dependent Induction of Matrix Metalloproteinase-2. First author DOI 10.1158/0008-5472.can-25-0887↗
- Editor's Note: RNA Interference Demonstrates a Novel Role for Integrin-Linked Kinase as a Determinant of Pancreatic Adenocarcinoma Cell Gemcitabine Chemoresist… Co-author DOI 10.1158/1078-0432.ccr-25-0820↗
- Withdrawal: CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells. Co-author DOI 10.1016/j.jbc.2023.105007↗
- Retraction notice to Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase (RRM2): a novel therapeutic strategy in pancre… Co-author DOI 10.1016/j.surg.2023.01.008↗
- Retraction notice to Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity [Surgery -September 2004, Pages… First author DOI 10.1016/j.surg.2023.01.009↗
- Retraction Note: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Co-author DOI 10.1038/s41388-023-02625-6↗
- Retraction Note: EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma. Co-author DOI 10.1038/s41388-023-02626-5↗
- Retraction Note: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine. Co-author DOI 10.1038/s41388-023-02627-4↗
- Editorial Expression of Concern: Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness. Co-author DOI 10.1038/s41388-023-02784-6↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stanley W. Ashley · 10 shared papers, 2023–2025 · strength 2.54
- Paper Editor's Note: A Novel Role for Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 as a Determinant of Gemcitabi… DOI 10.1158/0008-5472.can-25-0886↗
- Paper Editor's Note: RNA Interference Demonstrates a Novel Role for Integrin-Linked Kinase as a Determinant of Pancreatic Ade… DOI 10.1158/1078-0432.ccr-25-0820↗
- Paper Retraction: Prostaglandin E2 Enhances Pancreatic Cancer Invasiveness through an Ets-1-Dependent Induction of Matrix Met… DOI 10.1158/0008-5472.can-25-0887↗
- Edward E. Whang · 10 shared papers, 2023–2025 · strength 2.54
- Paper Editor's Note: A Novel Role for Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 as a Determinant of Gemcitabi… DOI 10.1158/0008-5472.can-25-0886↗
- Paper Editor's Note: RNA Interference Demonstrates a Novel Role for Integrin-Linked Kinase as a Determinant of Pancreatic Ade… DOI 10.1158/1078-0432.ccr-25-0820↗
- Paper Retraction: Prostaglandin E2 Enhances Pancreatic Cancer Invasiveness through an Ets-1-Dependent Induction of Matrix Met… DOI 10.1158/0008-5472.can-25-0887↗
- Hiromichi Ito · 7 shared papers, 2023–2025 · strength 1.83
- Paper Editor's Note: A Novel Role for Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 as a Determinant of Gemcitabi… DOI 10.1158/0008-5472.can-25-0886↗
- Paper Editor's Note: RNA Interference Demonstrates a Novel Role for Integrin-Linked Kinase as a Determinant of Pancreatic Ade… DOI 10.1158/1078-0432.ccr-25-0820↗
- Paper Retraction: Prostaglandin E2 Enhances Pancreatic Cancer Invasiveness through an Ets-1-Dependent Induction of Matrix Met… DOI 10.1158/0008-5472.can-25-0887↗
- Hiromichi Ito · 3 shared papers, 2023 · strength 0.71
- Paper Retraction notice to Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 … DOI 10.1016/j.surg.2023.01.009↗
- Paper Retraction Note: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenoca… DOI 10.1038/s41388-023-02625-6↗
- Paper Retraction Note: EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic a… DOI 10.1038/s41388-023-02626-5↗
- Thomas E. Clancy · 1 shared paper, 2025 · strength 0.28
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.